Searcharxiv⌕ Search

arXiv subjects

Shengxian Ding

Publications and source records attributed to Shengxian Ding.

2 recordsLinked to original sources

ELPAC: Endpoint-Anchored Latent Progression with Stage-Varying Multimodal Coordination

Aging cohorts increasingly combine imaging, plasma, and cognitive measurements, but most subjects provide only a partially observed cross-sectional snapshot, leaving latent stage, progression subtype, and stage-varying multimodal coordination to be inferred jointly. Existing methods estimate the cohort-level aging process, model covariance under observed covariates, or fuse modalities for prediction. However, they rarely target the joint problem of endpoint-anchored staging and progression-resolved residual coordination across modalities, even though subject staging, subtype assignment, and multimodal interplay are mutually dependent. We introduce ELPAC, a Bayesian framework with two interlocking constructions. The first integrates subtype trajectories backward from clinically reliable endpoint groups along biologically structured velocity components encoding modality-specific monotone direction and optional sequential ordering priors. The second factorizes residual multimodal variation around the inferred stage axis into sparse coordination axes whose loadings and activations expose which multimodal patterns are operative in each subtype and when they emerge, with stage-resolved variation supplying the auxiliary structure for conditional identifiability. We use a scalable amortized variational inference scheme that enables joint posterior inference at cohort scale with single-pass deployment on new subjects. On synthetic data and a harmonized ADNI+NACC/SCAN Alzheimer's cohort, ELPAC demonstrates accurate latent-structure recovery, well-calibrated prediction intervals, and biologically interpretable multimodal coordination programs that differ by subtype.

stat.ML↗

Disentangling Latent Risk Pathways via Bayesian Hypergraph Inference

Electronic health records (EHR) pose large-scale multi-disease modeling problems in which many outcomes are rare and strongly influenced by shared risk factors. While modern approaches achieve strong predictive performance, they often treat diseases independently or rely on black-box architectures, offering limited insight into how risk factors organize disease risk and little principled uncertainty quantification. We introduce a Bayesian hypergraph inference framework that reframes multi-disease modeling around latent, risk-factor-modulated disease pathways. Risk factors act on hyperedges, latent disease subsets with shared risk patterns, allowing diseases to participate in multiple distinct pathways and enabling interpretable, higher-order structure beyond pairwise associations. A repulsion prior encourages parsimonious and identifiable structure, while posterior inference provides calibrated uncertainty over both disease groupings and risk-factor influence. To enable scalable inference on large EHR datasets, we develop a structured variational inference algorithm that preserves logical dependencies among hyperedge existence, disease membership, and pathway-level effects. Experiments on simulated data and UK Biobank demonstrate stable and interpretable disease pathway structure, well-calibrated uncertainty, improved estimation for rare diseases, and competitive predictive performance.

stat.ML↗